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Nephrotoxic nephritis  (NTN) 1 is a  biphasic disease produced by the intravenous 
injection of heterologous antisera raised against a  variety of complex antigens and 
tissues (reviewed in 1). In the heterologous phase, the injected nephrotoxic antibodies 
(NTAb)  bind  to  the  glomerular  basement  membrane  (GBM)  and  cause  a  dose- 
dependent  proteinuria  (2)  that  is  usually  accompanied  by  C3  deposition  (3,  4), 
polymorphonuclear leukocyte (PMN) infiltration (4), endothelial swelling, and widen- 
ing of the GBM  (5,  6).  During the subsequent  autologous phase,  the host animal 
develops a humoral response against the kidney-bound NTAb (7). This results in the 
binding of host IgG to the GBM, additional C3 deposition, and the infiltration of 
mononuclear cells into glomeruli (8), leading to further proteinuria. 
The antigenic components within the GBM that bind NTAb have not been clearly 
identified. We attempted to produce NTN with antibodies directed solely against the 
basement  membrane  glyeoprotein  laminin  (9).  Laminin  is  isolated  (9)  from  the 
Englebreth-Holm-Swarm (EHS) sarcoma, a murine tumor that also secretes basement 
membrane collagen (10).  Additionally, laminin has been shown by immunological 
methods to exist in a  variety of basement membranes, including the GBM  (11-17). 
Thus, with affinity-purified sheep anti-laminin IgG, we sought to determine (a)  the 
distribution and amount of kidney-bound anti-laminin after intravenous administra- 
tion into rats and  (b)  what effects anti-laminin would have in vivo on the normal 
structure and function of the glomerulus. 
Materials and Methods 
Purification and Characterization of Laminin.  The  EHS  chondrosarcoma  was  maintained  by 
serial subcutaneous passage in Swiss-Webster mice. Laminin was purified by a modification of 
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the method of Timpl et al. (9). The 0.5 M NaCI tumor extract was applied to DEAE-cellulose 
equilibrated in deionized 2 M  urea in 0.05 M  Tris, pH 8.6, and the column was washed with 
the same buffer. A fraction of the bound proteins containing laminin was then eluted with the 
addition of 0.15  M  NaCI  in buffer and chromatographed  on  agarose  A  1.5  M  (Bio-Rad 
Laboratories, Richmond, CA) to obtain pure laminin. Electrophoresis was carried out in 5% 
polyaerylamide tube  gels  (18). The  amino acid  composition of the  purified  laminin was 
generously determined by Dr. Steven Krane of the Massachusetts General Hospital, Boston, 
MA. Laminin was also tested for cross-reactivity with anti-guinea pig fibronectin IgG that was 
a gift from Dr. Heinz Remold of our department. 
Preparation of Sheep Anti-Laminin  IgG (SaL).  Two male sheep were immunized against an 
EHS sarcoma homogenate emulsified in Freund's adjuvant, and IgG was purified by standard 
procedures. The monospecific anti-laminin fraction was obtained by passing the IgG over a 
column of' cyanogen bromide-activated Sepharose (Pharmacia Fine Chemicals, Div. of Phar- 
macia Inc., Piscataway, NJ) to which laminin had been coupled. The sheep IgG that failed to 
bind to laminin-Sepharose (SAT) was pooled and used in control experiments. Bound sheep 
anti-laminin  (S(xL) was eluted with 1 M propionic acid, pH 2.6, and dialyzed against phosphate- 
buffered  saline  (PBS).  The  SaL  was  centrifuged to  remove aggregates,  and  the  range of 
isoelectric  points of the SaL was determined by agarose gel isoelectrophoresis  as suggested by 
LKB (LKB, Stockholm, Sweden). 
Distribution of Intravenously Injected SaL by Immunofluorescence and Immunoelectron Microscopy.  The 
distribution of kidney-binding sites  for  SotL after  intravenous injection was examined by 
indirect immunofluoreseence microscopy.  12 rats weighing 150-200 g received injections of 
0.04-4 mg of S(~L in 1-2 ml of PBS. A total of six animals that received injections of normal 
sheep IgG (2), SaT (2), saline (1), or that were sham operated  (1) served as controls. 1-24 h 
after the injection, kidneys were removed and frozen sections 4-6 p.m thick were cut at -20°C 
and air dried. Sections were incubated with fluorescein-conjugated rabbit anti-sheep IgG (N. 
L. Cappel Laboratories, Inc., Cochranville, PA) and washed with PBS. 
The  distribution of kidney-bound SaL  was  also  determined by direct  immunoelectron 
microscopy. SaL was conjugated to horseradish peroxidase (HRP)  (type VI; Sigma Chemical 
Co.,  St.  Louis, MO)  (19), dialyzed against PBS,  and the isoelectric  range was measured as 
above. SaT was also conjugated to HRP and used in control experiments. Six male Sprague- 
Dawley rats, 125-175 g, were anesthetized, and 1-ml solutions of SaL-HRP that contained 0.65 
mg SaL bound to 0.5 mg HRP were injected intravenously.  SaT-HRP of the same concentration 
was injected into four additional animals. 1-2 h after injection, the left kidney of each animal 
was fixed in situ (20) with 1% formaldehyde and 3% glutaraldehyde in 0.1 M sodium cacodylate, 
pH 7.4 (21). Sections of cortex 40-~tm thick were incubat~ed in 0.05% diaminobenzidine  (DAB) 
and 0.01% H202 (22), pH 6.0, washed in buffer, and post~fixed in 2% OsO4 in 0.1 M phosphate, 
pH 7.3. Thin sections were stained for  1 min with lead citrate (23). 
Quantitation of Intravenously Injected SaL Bound to the Kidney.  SaL was radiolabeled with x2sI 
using the Iodo-gen reagent (Pierce  Chemical Co.,  Rockford, IL)  (24), and unbound 1~5I was 
removed by gel filtration. Concentrations of 0.04-4 mg of SaL that contained 100,000 cpm 
of [12~I]S(xL were injected intravenously into 23  150-g Sprague-Dawley rats.  1 h later, samples 
of blood and both kidneys from two animals were removed, weighed, and counted for x25I. 
The amount of SaL bound per kidney was  determined by the following formula: (mg SaL 
injected per animal) (percent of injected SaL in kidney)/(weight of kidney), and expressed  as 
/xg SaL/g kidney tissue. The remaining 21 animals were killed and counted 4 d later. 
Evaluation of Rats  That Recei~,ed Intravenous SaL Injections.  To evaluate the effect  of intrave- 
nously injected SaL on kidney function, rats that had received injections of 0.5-4 mg of SaL or 
SaT were maintained for  24-h periods in metabolic cages  up to  10 wk after injection. The 
amount of urinary protein  (Table I)  was  determined by the  Biuret  assay,  and differences 
between  the  SaL  and  SaT  rats  were  analyzed for  statistical significance by  a  one-tailed 
Student's t test.  Rats were killed at intervals (Table II), and their kidneys were examined for 
the continued presence of SaL and also for the deposition of rat C3 and rat IgG by indirect 
immunofluorescenee. In addition, sera taken at the time of killing was tested for the presence 
of rat anti-sheep IgG by double immunodiffusion. 
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TABLE I 
Urinary Protein Excretion (rag~24 h :t: SEM)* 
Day 
SaL injected 
1  5  7  14  21  28  42  50  70 
mg 
05  5.0±0.5(11)  8.4±0.9(5)  7.1±0.1(2)  11±0.2(2)  8.8:t:2.4(6)  6.3(1)  11.7±1.2(3)  5±0.4(2)  15(1) 
0.5-1,6  4.9±0.2(17)  6.2±2,2(3)  --  --  5±0.3(9)  --  --  5±0.1(4)  -- 
4.0  7.4:1:1,9 (7)  13.5 ±  4.2 (4)  9.3 ±  0.6 (3)  9.8 ±  1.3 (3)  16.4 ±  1.1 (3)  16.6 +  2.3 (3)  27.7 ±  5.3 (6)  --  28.7 ±  0.9 (3) 
* The number of rats measured  at each time point is shown  in parentheses. 
$ All rats in this category received 0.5-4,0 mg SaT. 
TABLE  II 
Number of Animals Sarapled  for Immunofluorescent and Electron Microscopy 
Time of sampling 
Treatment 
I-2 h  l  d  5 d  14 d  21 d  28 d  42 d  56 d  70 d 
0.5-1.6 mg SaL  4  (8)  --  (4)  4  5  2  --  2  -- 
1.5 mg SaT  1 (5)  (2)  1  1  1  --  1  -- 
4  mg SaL  --  2  ....  3  --  3 
4  nag SaT  --  1  ....  1  --  I 
Uninjeeted  2 
Kidneys from animals that were examined by immunofluorescent  microscopy only are shown  in parentheses. All others were examined by both 
fluorescence mictx)scopy and electron microeazopy. 
also evaluated at intervals by electron microscopy (Table II). Blocks of kidney cortex that were 
fixed in aldehydes as described above were post-fixed in 1% OsO4 in veronal-acetate buffer, pH 
7.4, and stained en bloc with uranyl acetate (25). Thin sections were stained for 5 min each 
with uranyl acetate and lead citrate (23). 
Results 
Characterization of Laminin and SaL.  The yield of laminin was -90 mg from 100 g 
wet weight of the EHS tumor. The reduced protein migrated as two prominent bands 
of ~440,000  and  220,000  Mr  in sodium  dodeeyl sulfate gels  (Fig.  1), as previously 
reported (9).  Other clearly defined species were not seen, even when the gels were 
grossly overloaded with 300/~g of protein. When unreduced, laminin barely entered 
a 5% polyacrylamide gel. 
The amino acid composition of this laminin preparation is shown in Table III and 
is similar to that published previously (9), although we detected higher amounts of 
half-cysteine and isoleucine, a  lower amount of glycine, and no hydroxylysine. Both 
laminin preparations differ considerably from the amino acid composition of collagen 
type IV  (26)  and  fibronectin (27)  (Table III).  Finally, IgG that  was  purified from 
antisera against  fibronectin failed to bind purified laminin,  as shown by others  (9, 
Ii). 
Monospecific sheep anti-laminin IgG (SaL) was purified by immunoabsorption of 
sheep anti-tumor IgG on laminin-Sepharose. By Ouehterlony immunodiffusion, SaL 
gave a single precipitin band of identity when developed against either pure laminin 
or the crude laminin extract (data not shown). The isoelectric points of SaL ranged 
from 4.6-7.1  (Fig. 2), as did the majority of IgG in the sheep anti-tumor preparation. 
Localization of Kidney-binding Sites for  Intravenously Injected SaL.  Within  1 h  after 
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Fro.  1.  5% polyacrylamide gels of laminin preparations. Tube A contains reduced proteins eluted 
from the DEAE column in 0.15 M NaC1, 2 M Urea, and 0.05 M Tris, pH 8.6. Tube B contains 
reduced laminin obtained at the end of purification. The upper band is ~440,000 mol wt and the 
lower is 220,000 mol wt. Smearing below the lower band is only seen when high sample loads; in 
this case 300 #g is applied to the gel (compare with tube A). Other molecular weight species are not 
seen. Tube C contains unreduced laminin (300 #g) that barely enters the gel. 
rescence (Figs. 3 and 4). The GBM in all glomeruli stained intensely but the binding 
of SaL  to the TBM was focal and occurred only in rats that  received injections of 
>0.5  mg  SaL  (Fig.  4).  Throughout the  GBM  and when present  in the TBM,  the 
binding was linear in all 12 rats examined. Binding to the tubular epithelium was not 
observed, and SAL was not present within the urinary spaces.  When normal sheep 
IgG or SaT was injected into each of six rats, no binding to any kidney structure was 
seen. 
The distribution of SaL was also examined by electron microscopy. 1-2 h  after the 
injection of SaL-HRP conjugates (pI  4.6-7.1;  Fig.  2),  peroxidase reaction product 
was found throughout the full thickness of the GBM and mesangial matrix (Fig. 5). 
Endocytic  uptake  of  SaL  by  mesangial,  endothelial,  or  epithelial  cells  was  not 
observed, however. Peroxidase was also not seen within the urinary space nor within 
tubular epithelial cells. SaL-I-IRP was bound, however, to some areas of the TBM. In 132  ANTI-LAMININ  IgG  IN  RAT  KIDNEY  BASEMENT  MEMBRANES 
TABLE  III 
Amino Acid Composition 
Laminin  Laminin*  Human fibronectin$  Type IV collagen§ 
Asp  125  109  92  53 
Thr  52  58  97  34 
Ser  72  77  68  57 
Glu  117  122  116  102 
Pro  49  53  76  65 
Gly  79  93  80  281 
Ala  72  76  43  44 
Half-Cys  52  30  26  7 
Val  40  48  81  28 
Met  12  14  11  13 
Ile  67  42  44  25 
Leu  83  92  57  52 
Tyr  30  27  45  9 
Phe  29  31  27  29 
Lys  48  52  36  11 
His  23  24  21  11 
Arg  49  50  52  32 
Hyl  0  2  0  37 
3-Hyp  0  0  0  6 
4-Hyp  0  0  0  104 
Trp  NDII  ND  ND  ND 
*  From reference 9. 
$  From reference 27. 
§  From reference 26. 
I Not determined. 
Flo.  2.  Isoelectric focusing in agarose.  Lane A, sheep anti-tumor homogenate serum; lane B, anti- 
tumor homogenate IgG; lane C, SaL; lane D, SaL-HRP.  The isoelectric  points of SaL and SaL- 
HRP range from 4.6-7.1. Sheep albumin (1) and hemoglobin (2) serve as internal standards. 
control  animals  that  received  injections  of  SaT-HRP,  peroxidase  was  not  present 
within  the GBM,  mesangial  matrix,  (Fig.  6)  or TBM. 
Quantitation  of  Kidney-bound [12~I]SaL.  When  injected  intravenously  into  rats, 
[125I]SaL  rapidly  bound  to  the  kidney,  and  ~1.6%  of  an  administered  dose  was 
measured  within  each kidney after  1 h.  4  d  later,  the amount  of kidney-bound  [125I]- 
SaL  was  ~2%  of  the  injected  dose  over  the  range  of  0.04-0.95  mg  and  equaled DALE R.  ABRAHAMSON AND JOHN P.  CAULFIELD  133 
FIG. 3 and 4.  Fluorescence  micrographs of  the renal cortex from rats that had received intravenous 
injections of SaL 60 rain previously. The frozen sections were stained with fluorescein rabbit anti- 
sheep IgG. Fig. 3 is taken from a rat that had received 0.4 mg SaL. The glomeruli (G) stain intensely 
but little staining of the TBM is evident. Fig. 4 is taken from an animal that had received 4 mg 
SaL. The glomeruli fluoresce intensely and areas of the TBM (arrows) also stain for sheep IgG at 
this higher dose (compare with Fig. 3). 
0.65-19/tg/g  kidney  (Fig.  7).  In contrast,  when  4  mg of [12~I]SaL was injected,  62 
#g/g kidney or  1.5%  of the administered  dose was bound.  The amount  of unbound 
[12~I]SaL within the renal circulation was calculated to be <3% of the bound SaL and 
therefore was ignored. 
Acute Effects of SaL.  Rats  that  received  0.5-1.6  mg SaL  intravenously  had  the 
same urinary protein concentration as normal and SaT-injected rats  (4.9-8.4 rag/24 
h)  for the first  5  d  after injection  (Table  I). Those animals  that  received  4  mg SaL 
averaged 7.4 mg during the first 24 h  and  13.5 mg/24 h  5 d  later, but these values did 
not differ significantly from the controls  (P >  0.05). 
Immunofluorescent  examination  of kidneys  from  all  animals  that  received  SaL 
yielded similar results for the distribution  of SaL, rat C3, and rat  IgG from  I  h  to 5 
d  after  injection.  Over this  time period,  SaL remained  bound  to the GBM and,  in 
doses above 0.5 rag, to the TBM in a  linear pattern.  Rat C3 was present within some 
glomeruli in a  few animals but was completely absent in most  (Fig. 8  a, b).  Portions 
of the TBM stained for C3 in all animals  (Fig. 8  b).  In contrast, homologous rat IgG 
was not present  in the GBM or TBM of any rat. Control rats receiving SaT did not 
have  renal-bound  sheep  IgG or rat  IgG, but  rat  C3  was  again  occasionally found 
bound to the TBM.  Electron  microscopic examination  revealed  normal  glomerular 
architecture and no evidence of cellular infiltration  1 h- 1 d  after the injection of SaL 
or SaT. 
Long-Term Effects of SaL.  At longer intervals after SaL injection, all rats appeared 
healthy, and their kidneys were grossly normal.  Proteinuria was not observed in any 
rat receiving <1.6 mg SaL up to 50 d  after injection  (Table I). In contrast, rats that 
received  4  mg SaL  became  mildly  proteinuric  within  3  wk  (16.4  mg/24  h).  Mean FIG.  5.  Electron micrograph of a portion of a glomerutus from a rat that received an intravenous 
injection of SaL-HRP  1 h before killing. Peroxidase reaction product is present throughout the full 
thickness of the GBM and mesangial matrix  (MM). The endocytic uptake of HRP by mesangia[ 
(Me), endothelial (En), or epithelial cells (Ep)  is not seen. Erythrocytes (RBC)  stain intensely for 
HRP because of the peroxidatic activity of hemoglobin. Magnification, 7,600×. Scale bar, 2/zm. 
Fro.  6.  Glomerulus from a control rat that had received SaT-HRP  1 h before fixation. Peroxidase 
is absent from the GBM and mesangial matrix  (MM). Deeply stained erythrocytes (RBC)  assure 
adequate penetration of H202, DAB, and OsO4. Magnification, 7,600×. 
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Fro.  7.  Plot of [I~I]SaL binding to the kidney 4 d after injection.  The amount of kidney-bound 
SaL increases proportionally to the injected dose over the dose range of 0.04-0.95  mg and averages 
~2%. The amount of kldney-bound S0tL at 4 mg, however, is 1.5% of the injected dose. 
Fro.  8.  Frozen sections  from the kidneys  of S~tL-injected rats that were stained with fluorescein- 
goat anti-rat C3. (a) kidney from a nonproteinuric rat 5 d after the injection of SaL. The glomerulus 
and adjacent TBM fluoresce  intensely.  (b)  in contrast, the animal shown  was injected with 4 mg 
SaL 10 wk previously and was proteinuric. There is only trace staining of the glomerulus and intense 
focal staining of the TBM. Because similar staining was also seen in normal rats, SaT-injected rats, 
and most rats within the first 5 d after SaL injection, this pattern probably represents  background. 
(a) Magnification, 350X; (b) Magnification, 500×. 
urinary  protein  excretion  increased  to  27.7  mg/24  h  at  6  wk,  and  this  condition 
persisted  until  10  wk  (28.7  rag/24  h).  The  differences  between  the  proteinuric  and 
control  rats  were  statistically  significant  (P <  0.05)  at  the  3-  and  6-wk  time  points 
and,  when  the urinary  protein  readings  from  the rats  that  received 4  mg  SaL  at  all 
time points were pooled  and  compared  with the controls,  over the entire study  (P < 
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Kidneys were examined  as  before  for the  presence  of sheep  IgG, rat  C3,  and  rat 
IgG. Large amounts of sheep IgG remained bound in the GBM and TBM until killing 
in all animals that received SaL injections. However, the distribution of bound  SaL 
changed over time, and the amount of SaL present in the peripheral GBM appeared 
to  diminish  progressively (compare  Fig.  9 a  and  9 b).  In  contrast,  mesangial  areas 
stained  intensely for sheep  IgG  10  wk  after SaL  injection  (Fig.  9 b),  whereas  only 
moderate mesangial staining was noted in animals that were examined after 1 d  (Fig. 
9 a).  Rat  C3 was again observed bound  to the GBM  and TBM  in some but  not  all 
rats  that  received SaL, as  noted  in  the  acute  time period.  No  correlation was  seen 
between  C3  deposition and  proteinuria,  however,  because  most  mildly proteinuric 
animals  lacked  C3  in  their  glomeruli  and  some  nonproteinuric  rats  had  focal  C3 
deposition. Homologous rat IgG, in contrast, was not detected bound to the GBM or 
TBM  at any time in any animal throughout  the experiment. In addition, sera from 
the proteinuric animals failed to immunoprecipitate SaL or normal sheep IgG. At all 
time points, neither sheep  nor rat  IgG was present  in  the kidneys from  control rats 
that received SaT. Variable, focal staining of the TBM for rat C3 was again observed. 
Kidneys  from  19  rats  that  had  received  injections  of 0.5-4  mg  SaL  2-10  wk 
previously  (Table  l)  were  examined  by  electron  microscopy.  In  all  of these,  the 
glomeruli  contained  focal  abnormalities  that  were  not  evident  when  examined  by 
light microscopy and not present in control or normal rats. 
The  most  prominent  and  frequent  change  seen  in  all animals  that  received SaL 
FIo. 9.  Fluorescence micrographs of glomeruli from rats that received 4 mg SaL and that were 
stained for the presence of  sheep IgG. (a) 1 d after SaL injection, sheep IgG is distributed in a linear 
pattern throughout  the GBM. (b) 10 wk after SAL injection, the GBM does not stain with the same 
intensity as seen in part a. In contrast, the mesangial regions of the glomerulus (arrows) fluoresce 
intensely, suggesting the SaL moves from the GBM to the mesangium with time. Magnification in 
a and b, 900X. DALE  R.  ABRAHAMSON AND JOHN  P.  CAULFIELD  137 
was GBM thickening. Flocculent, subendothelial deposits were seen in the GBM 2 wk 
after  the  injection  of SaL,  and  by  6  wk,  focal  areas  of greatly  increased  width 
measuring  as  much  as  1.5  #m  (normal  is  0.15  #m;  ref.  20)  were  present  in  the 
peripheral capillary (Fig.  10 a). These deposits contained  250 ,~ fragments of mem- 
brane, and projections of the endothelial cytoplasm extended into them (Fig.  10 a). In 
addition  to deposits within  the lamina rara interna,  the width of the lamina densa 
was  often  increased  (Fig.  10 a),  and  in  some  areas  the  lamina  densa  was  split  or 
reduplicated into as many as four distinct layers (Fig.  10 b). The lamina rara externa, 
in contrast, appeared normal in all animals, and subepithelial deposits were not seen. 
The second most common finding was the presence of small numbers of mononu- 
clear cells within  the glomerular capillary lumen.  This was seen in all SaL-injected 
rats  and  appeared as  early as  2-3 wk after injection.  The  mononuclear  cells  were 
often attached to the peripheral capillary wall at the point ofsubendothelial deposits 
(Fig.  11).  Pseudopodia  extended  beneath  the endothelium,  and  vesicles containing 
electron-dense material were present within the monocyte cytoplasm adjacent to the 
deposits. In other areas, larger pseudopodia extended for several microns beneath the 
endothelium and appeared to displace the endothelium from the GBM (Fig.  12). This 
might have resulted in the complete removal of portions of the endothelium because 
areas of the GBM were seen that were denuded of endothelium  (Fig.  13). PMN were 
rarely observed within glomeruli at any time point and were never seen attached to 
the capillary wall. 
Minor changes were seen in the mesangium and glomerular epithelium.  Electron- 
dense deposits were not present within the mesangial matrix. At 6 and 10 wk after the 
injection  of 4  mg SaL,  however, some glomerular capillaries  in  all  rats were filled 
with mononuclear ceils, but a clear distinction between mesangial cells and infiltrating 
mononuclear cells was not possible (Fig. 14). In the epithelial cells, absorption droplets 
or lysosomes were present in the cytoplasm (Fig.  15), slit diaphragms were displaced 
(Figs. 10 b and 11), and surface microvilli protruded into the urinary space (Fig. 10 a). 
Normal, uninjected animals and animals injected with SaT had none of the changes 
described  above.  In  addition,  the  morphology of the  tubular  epithelium  and  the 
ultrastructure of the TBM appeared normal in all SaL- and SaT-injected animals. 
Discussion 
These  studies  demonstrate  that,  after  intravenous  injection  into  rats,  affinity- 
purified SaL rapidly bound throughout the GBM. The bound SaL, at concentrations 
that appeared to saturate the glomeruli, failed to cause significant proteinuria within 
the first 5 d.  Rats that  received a  single injection of 4  mg SaL, however, gradually 
developed a mild proteinuria over a  3-10 wk period that appeared to be glomerular 
in origin because structural changes were confined to the glomerulus. The proteinuria 
might have been caused by an irregular, increased thickening of the GBM, mononu- 
clear cell infiltration,  or the stripping of the endothelium  from the GBM.  However, 
these lesions did not  result  from a  host  humoral response typical of the autologous 
phase of NTN (3,  7)  because rat IgG was not present within the GBM and rat anti- 
sheep IgG was not detected in the serum of affected animals. These results therefore 
resemble the proteinuria and structural changes seen in the autologous phase of NTN, 
but dissociate these changes from the earlier or heterologous phase and the subsequent 
humoral response. Fie.  10.  Examples of thickened GBM from rats that received 4 mg SotL 6 wk before killing. (a) the 
endothelium  (En)  has few fenestrations and extends spike-like projections between subendothelial 
deposits. The deposits contain spherical membrane fragments (arrowheads). The lamina densa (1 d) 
is abnormally wide,  measuring 270 nm. Microvilli  (arrows)  extend from the epithelium  (Ep)  into 
the urinary space (US). CL, capillary lumen. Magnification, 31,500×.  Scale bar,  1/zm.  (b) a  large 
knuckle of thickened GBM is seen in the center of the picture  (GBM), and the GBM is split  into 
four distinct layers on the right (arrowheads). Some of the epithelial slit diaphragms  (large arrows) 
are  displaced  from  the GBM.  Normally  located  diaphragms  are  on  the  right  of the micrograph 
(small arrows). Magnification, 24,000×.  Scale bar,  1/~m. 
138 FIG.  11.  Monocytic cell attached to the peripheral capillary wall from a  rat injected with  1.6 mg 
Sc~L four wk before killing. The monocyte (M)  is extending a pseudopod beneath the endothelium 
(En)  and  abutting on  the subendothelial deposit  (d).  Small  intracellular  vesicles  (small arrows) 
within the monocyte contain material similar in electron density to the deposit. There is a displaced 
slit diaphragm (arrow)  between two epithelial cells (Ep). Subendothelial deposits are not observed 
within the apparently normal GBM at the lower part of the micrograph. Magnification, 32,500×. 
Scale bar,  1 #m. 
FE~.  12.  Mononuclear cell  (M)  attached to the GBM  from a  rat  that  received 4  mg SaL  10 wk 
earlier. Long pseudopodia have inserted beneath the endothelium (En) and have displaced a broad 
region of the endothelium from the GBM. Ep, epithelium. Magnification, 18,500×. Scale bar,  1 btm. 
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FxG.  13.  Peripheral glomerular capillary from a  rat that received 4  mg St~L 6  wk before killing. 
The endothelial cell  layer  (En)  is absent from the GBM over a  span of >3 #m. This is possibly 
because of the earlier  infiltration of mononuclear cells, such as is shown in  Figs.  11  and  12.  US, 
urinary space; CL, capillary lumen. Magnification, 31,000×. Scale bar,  1/tm. 
Ftc.  14.  Portion of a  glomerulus from a  rat that received an injection of 4 mg SaL  10 wk before 
killing. The capillary loops are congested with large, mononuclear cells. These cells abut the GBM 
in several broad areas (arrowheads). Ep, epithelium. Magnification, 8,300×. DALE R. ABRAHAMSON AND JOHN P.  CAULFIELD  141 
FIo.  15.  Micrograph from a  protcinuric rat  that  had  received 4  mg SaL  10 wk previously. 
Numerous absorption droplets or lysosomes  (arrows) are present within the epithelial cell (Ep). CL, 
capillary lumen, US, urinary space. Magnification, 22,000)<. Scale bar, 1  #m. 
The binding of SaL to the GBM, TBM, and mesangium was highly immunospecific 
because antibody from the same sheep IgG preparation that failed to bind laminin- 
Sepharose (SAT) did not bind to any renal structure. Nonspecific ionic interactions of 
SaL  with  the  fixed  negative  charges  of the  GBM  (28),  such  as  that  seen  in  the 
glomerular  binding  of cationized  ferritin  (29,  30),  were  also  unlikely  because  the 
isoelectric points of SaL measured from 4.6-7.1. In addition, SaL bound very rapidly 
to kidney basement membranes because 80% of the amount bound at 4 d was bound 
within  the  1st  h  after  injection.  A  similar  rapid  binding  is  seen  for  heterologous 
nephrotoxic  antibodies  (NTAb)  (2)  that  are  directed  against  complex  mixtures  of 
kidney antigens. 
The  binding  of monospecific  SaL  to  the  kidney  differed  from  the  binding  of 
polyspecific NTAb in several respects, however. First, the binding of SaL was more 
diverse because, at injected doses above 0.5 mg, SaL bound to both GBM and TBM, 
whereas NTAb apparently binds exclusively to the GBM, even at doses that saturate 
the kidney (1, 2). Second, glomerular laminin apparently became saturated with SaL 
at  injected  doses  of 0.5  mg,  because,  at  high  doses,  SaL  also  bound  to  the  TBM 
without  an apparent increase in the immunofluorescenee of the glomeruli. Third,  if 
the glomerular binding was indeed saturated at 0.5 mg of injected SaL, the maximum 
amount of SaL bound to glomeruli at this and higher doses was l0 #g/g kidney. This 
amount is far less than the  175 #g of glomerular-bound NTAb thought  necessary to 
cause immediate proteinuria  (1,  2)  and might explain why injections of up to 4  mg 
SaL did not induce acute damage. However, the fact that SaL did not consistently 
induce complement deposition  in  the GBM or stimulate PMN  infiltration,  both of 
which  have been shown to cause proteinuria after the injection  of NTAb  (1,  3,  4), 
might  be  equally  important.  The  lower  levels  of  SaL  binding  and  variable  C3 
deposition  might  also  have  accounted  for  the  failure  to  generate  subendothelial 142  ANTI-LAMININ IgG IN RAT KIDNEY BASEMENT MEMBRANES 
deposits,  GBM  thickening,  and  endothelial  exfoliation  in  the  first  few  days  after 
injection, as occurs in the heterologous phase of NTN (5, 6). 
The etiology of the proteinuria in rats that received 4 mg SaL and started 3-6 wk 
after the injection of 4 mg SaL is unclear. The lesion was not caused by the glomerular 
deposition of homologous rat anti-sheep antibody because rat IgG was not found in 
the GBM and rat anti-SaL was not present in the sera. Proteinuria was probably not 
caused  by  complement  either  because  there  was  no  change  in  the  amount  of 
glomerular C3 detected subsequent to the acute period and because most proteinuric 
animals had no complement in their glomeruli. The reason for proteinuria, however, 
was most probably due to changes  that occurred within  the glomeruli  because the 
epithelial  cells had  absorption  droplets  (31-33),  microvilli formation  (34),  and  dis- 
placed slit  diaphragms  (33,  35),  all of which  are changes  seen  in  other glomerular 
proteinurias. 
The  two  most  likely explanations  for the  development  of proteinuria  are GBM 
injury and mononuclear cell infiltration with subsequent endothelial stripping.  Both 
lesions  were  seen  2-3  wk  after  SaL  injection  at  about  the  time  of the  onset  of 
proteinuria.  However,  both  lesions  were  also  present,  although  qualitatively  less 
severely, in nonproteinuric rats that received doses of <4 mg SaL. Thickening of the 
GBM was caused by both the formation of amorphous subendothelial  deposits and 
an increase in the breadth of the lamina densa. The composition of the subendothelial 
deposits is unknown but they clearly did not contain rat IgG or rat C3, both of which 
are believed to occur in similar deposits that are seen in NTN (6). The deposits might 
have contained, however, SaL, laminin, or other GBM components in addition to cell 
debris. The reason for thickening of the lamina densa is also unknown.  Perhaps the 
cross-linking of laminin molecules by SaL decreased the normal degradation of GBM 
components and resulted in focal areas of increased thickness. 
Monocytes have been recently associated with proteinuria  in several examples of 
glomerulonephritis.  Proteinuria  can  be  prevented  by  the  administration  of anti° 
macrophage serum (36), and mononuclear infiltrates are correlated with proteinuria 
in both serum sickness (37)  and an accelerated model of NTN (8).  Monocytes might 
endocytose deposits from beneath the endothelium and improve glomerular filtration, 
as suggested by others (38). On the other hand, the adherence of mononuclear cells to 
the GBM might damage the capillary wall because in our experiments the endothe- 
lium was lifted off of the GBM by the cells and, in areas, was completely removed. A 
similar  process  occurs  in  the  heterologous  phase  of  NTN  where  PMN  infiltrate 
beneath  the  endothelium  and  partially  remove it,  although  this  defect  is  repaired 
within a  few days (39, 40). 
The failure of up to 4 mg SaL to stimulate an anti-sheep IgG response in the rat 
was  surprising.  This  might  have  been  due  to  the  removal  of SaL  aggregates  by 
centrifugation  before injection  because monomeric IgG is  a  poor immunogen  (41). 
Alternatively, because we used affinity-purified antibody rather than a  mixed anti- 
body preparation, the injected SaL might have combined with laminin in renal and 
extrarenal  sites,  and  adequate  amounts  of  free  sheep  IgG  might  not  have  been 
available for the appropriate stimulation of a humoral response. However, others (7) 
who have injected  3.5  mg polyspecific NTAb  have observed the  development of a 
host  humoral response, although  the injection of 1.5  mg NTAb or less was deemed 
inadequate  to  stimulate  host  antibody  formation.  In  the  absence  of  a  humoral DALE R.  ABRAHAMSON AND JOHN P. CAULFIELD  143 
response, perhaps the injection of 4 mg St~L was sufficient to stimulate a cell-mediated 
(delayed-type) reaction within  glomeruli  (42)  that  might  have contributed  to  the 
functional and structural changes that we observed. 
These experiments demonstrate that  laminin is distributed throughout the GBM 
and mesangial matrix. This finding is in partial agreement with the work of others 
who have localized laminin variously to the mesangium (11-13, 15), the lamina rarae 
(13,  14), the lamina rata interna and lamina densa but not the lamina rara externa 
(12), as well as to Bowman's capsule (11-13, 15) and the TBM (11-13, 15, 43). Apart 
from species  differences and  the  use of direct vs.  indirect labeling techniques,  the 
discrepancies that exist between all of these studies are probably also the result of the 
method of antibody delivery, i.e., the in vivo permeability of the GBM to immuno- 
logical tracers might differ from the permeability in vitro. Finally, our experiments 
indicate that SaL and presumably the laminin to which it is bound are cleared from 
the peripheral GBM by a gradual translocation into the mesangium. This is the same 
pathway proposed for normal GBM turnover on the basis of silver nitrate-labeling 
studies (44). 
Summary 
Antibodies  against  laminin,  which  is  a  defined glycoprotein of basement  mem- 
branes,  were  produced  in  sheep  and  affinity  purified  by  immunoadsorption  on 
laminin-Sepharose (SaL). When injected intravenously into rats, SaL rapidly bound 
in a  linear pattern to the glomerular basement membrane (GBM) in the peripheral 
and mesangial regions of all glomeruli, and, when >0.5 mg SaL was injected, to some 
tubular BM as well.  1-2 h after the injection of conjugates of horseradish peroxidase 
(HRP) and SaL, HRP reaction product was present throughout the full thickness of 
the GBM and mesangial matrix.  [125I]SaL binding to the kidney in vivo increased 
linearly over the  dose range of 40-950/zg  of IgG and  accounted  for ~2%  of the 
injected dose/g kidney. When 4 mg of [I~I]SaL was injected, 1.5% or 62/~g/g kidney 
was bound. Proteinuria did not develop within 7 wk of injection in rats that received 
0.5-1.6 mg of SaL. In contrast, all animals that received injections of 4 mg of SaL 
gradually became proteinuric within 3-6 wk. Thickening, reduplication, and floccu- 
lent subendothelial deposits were observed in the GBM of these animals. In addition, 
mononuclear cells adhered  to  the GBM and  infiltrated  beneath  the  endothelium. 
However, the deposition of rat C3 was infrequently observed, and rat IgG was not 
seen in the glomeruli of any rat that received SaL. 10 wk after injection, much greater 
amounts of SaL appeared within the mesangium than the peripheral GBM. These 
results demonstrate that  the interaction of SaL with the GBM, possibly in concert 
with infiltrating mononuclear cells, gradually altered the structure and permeability 
characteristics of the glomerulus independent of a host anti-SaL humoral response. 
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